| Rebecca Deanne King, LEP | |
|
20717 South St Ste C, Tehachapi, CA 93561-6444 | |
| (661) 376-3683 | |
| Not Available |
| Full Name | Rebecca Deanne King |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 20717 South St Ste C, Tehachapi, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265206379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 4121 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Deanne King, LEP 23480 Lakeview Dr, Tehachapi, CA 93561-9157 Ph: (661) 376-3683 | Rebecca Deanne King, LEP 20717 South St Ste C, Tehachapi, CA 93561-6444 Ph: (661) 376-3683 |
News Archive
A single chemotherapy treatment can result in a significant negative impact on walking gait and balance, putting patients at an increasing risk for falls, according to a new study involving breast cancer patients conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
In the emerging field of tissue engineering, scientists encourage cells to grow on carefully designed support scaffolds. The ultimate goal is to create living structures that might one day be used to replace lost or damaged tissue, but the manufacture of appropriately detailed scaffolds presents a significant challenge that has kept most tissue engineering applications confined to the research lab.
RemitDATA, an expert in reimbursement, productivity and utilization solutions in outpatient healthcare, today launched TITAN, a new, data-rich solution that provides a real-time, transparent view of essential business metrics.
Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.
Although Parkinson's disease is often associated with motor symptoms such as stiffness, poor balance and trembling, the first symptoms are often sensory and include a reduced sense of touch and smell. In a study on mice, researchers at Karolinska Institutet have now been able to identify neural circuits and mechanisms behind this loss of sensory perception.
› Verified 8 days ago
Dr. Kathleen Stroup Neal, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 24900 Highway 202, California Correctional Institution, Tehachapi, CA 93561 Phone: 661-557-5657 Fax: 661-823-3362 | |
Robert Knol, MD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1300 Scarlet Oak Dr, Tehachapi, CA 93561 Phone: 661-823-3339 | |
Susan Louise Holley, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 798 Tucker Rd Ste 1, Tehachapi, CA 93561 Phone: 661-206-8108 Fax: 661-821-9752 | |
Dr. John Ponder, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 20430 Brian Way, Suite 2, Tehachapi, CA 93561 Phone: 619-813-7154 | |
Dr. Hilary Trytten, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 905 Acacia Ct, Tehachapi, CA 93561 Phone: 661-238-3183 | |
Dr. John Baird Iii, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: End Of Hwy 202, Tehachapi, CA 93561 Phone: 661-822-4402 |